請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/25109
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 翁啟惠(Chi-huey Wong) | |
dc.contributor.author | Peishan Lee | en |
dc.contributor.author | 李佩珊 | zh_TW |
dc.date.accessioned | 2021-06-08T06:02:32Z | - |
dc.date.copyright | 2007-07-31 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-07-25 | |
dc.identifier.citation | Section I.
Akira, S and Takeda, K (2004). 'Toll-like receptor signalling.' Nat Rev Immunol 4(7): 499-511. Alexander, C and Rietschel, ET (2001). 'Bacterial lipopolysaccharides and innate immunity.' J Endotoxin Res 7(3): 167-202. Angus, DC and Wax, RS (2001). 'Epidemiology of sepsis: an update.' Crit Care Med 29(7 Suppl): S109-16. Arend, WP, Malyak, M et al. (1998). 'Interleukin-1 receptor antagonist: role in biology.' Annu Rev Immunol 16: 27-55. Arend, WP, Welgus, HG et al. (1990). 'Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.' J Clin Invest 85(5): 1694-7. Baeuerle, PA and Henkel, T (1994). 'Function and activation of NF-kappa B in the immune system.' Annu Rev Immunol 12: 141-79. Boehm, U, Klamp, T et al. (1997). 'Cellular responses to interferon-gamma.' Annu Rev Immunol 15: 749-95. Brown, GD and Gordon, S (2003). 'Fungal beta-glucans and mammalian immunity.' Immunity 19(3): 311-5. Chai, Z, Gatti, S et al. (1996). 'Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice.' J Exp Med 183(1): 311-6. Chen, CY and Shyu, AB (1995). 'AU-rich elements: characterization and importance in mRNA degradation.' Trends Biochem Sci 20(11): 465-70. Chen, HS, Tsai, YF et al. (2004). 'Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides.' Bioorg Med Chem 12(21): 5595-601. Chen, HS, Tsai, YF et al. (2004). Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorg Med Chem. 12: 5595-601. Chien, CM, Cheng, JL et al. (2004). 'Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56+ NK-cell cytotoxicity in cord blood.' Bioorg Med Chem 12(21): 5603-9. Coelho, AL, Hogaboam, CM et al. (2005). 'Chemokines provide the sustained inflammatory bridge between innate and acquired immunity.' Cytokine Growth Factor Rev 16(6): 553-60. Del Prete, G, De Carli, M et al. (1993). 'Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production.' J Immunol 150(2): 353-60. Dinarello, CA, Cannon, JG et al. (1991). 'Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells.' Brain Res 562(2): 199-206. Dinarello, CA, Cannon, JG et al. (1988). 'New concepts on the pathogenesis of fever.' Rev Infect Dis 10(1): 168-89. Doherty, GM, Lange, JR et al. (1992). 'Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.' J Immunol 149(5): 1666-70. Fiorentino, DF, Bond, MW et al. (1989). 'Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.' J Exp Med 170(6): 2081-95. Galanos, C (1975). 'Physical state and biological activity of lipopolysaccharides. Toxicity and immunogenicity of the lipid A component.' Z Immunitatsforsch Exp Klin Immunol 149(2-4): 214-29. Galanos, C, Hansen-Hagge, T et al. (1985). 'Comparison of the capacity of two lipid A precursor molecules to express the local Shwartzman phenomenon.' Infect Immun 48(2): 355-8. Grutz, G (2005). 'New insights into the molecular mechanism of interleukin-10-mediated immunosuppression.' J Leukoc Biol 77(1): 3-15. Haziot, A, Chen, S et al. (1988). 'The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage.' J Immunol 141(2): 547-52. Hodgson, JC (2006). 'Endotoxin and mammalian host responses during experimental disease.' J Comp Pathol 135(4): 157-75. Hsu, HY, Hua, KF et al. (2004). 'Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathways.' J Immunol 173(10): 5989-99. Jenkins, JK, Malyak, M et al. (1994). 'The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils.' Lymphokine Cytokine Res 13(1): 47-54. Jones, SA (2005). 'Directing transition from innate to acquired immunity: defining a role for IL-6.' J Immunol 175(6): 3463-8. Kawai, T, Adachi, O et al. (1999). 'Unresponsiveness of MyD88-deficient mice to endotoxin.' Immunity 11(1): 115-22. Kim, GY, Ko, WS et al. (2006). 'Water extract of Cordyceps militaris enhances maturation of murine bone marrow-derived dendritic cells in vitro.' Biol Pharm Bull 29(2): 354-60. Kim, HG, Shrestha, B et al. (2006). 'Cordycepin inhibits lipopolysaccharide-induced inflammation by the suppression of NF-kappaB through Akt and p38 inhibition in RAW 264.7 macrophage cells.' Eur J Pharmacol 545(2-3): 192-9. Kim, KM, Kwon, YG et al. (2003). 'Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-kappaB activation.' Toxicol Appl Pharmacol 190(1): 1-8. Ko, KM and Leung, HY (2007). 'Enhancement of ATP generation capacity, antioxidant activity and immunomodulatory activities by Chinese Yang and Yin tonifying herbs.' Chin Med 2: 3. Kuo, CF, Chen, CC et al. (2005). 'Cordyceps sinensis mycelium protects mice from group A streptococcal infection.' J Med Microbiol 54(Pt 8): 795-802. Kuo, MC, Chang, CY et al. (2007). 'Immunomodulatory effect of exo-polysaccharides from submerged cultured Cordyceps sinensis: enhancement of cytokine synthesis, CD11b expression, and phagocytosis.' Appl Microbiol Biotechnol 75(4): 769-75. Kuo, YC, Tsai, WJ et al. (2001). 'Regulation of bronchoalveolar lavage fluids cell function by the immunomodulatory agents from Cordyceps sinensis.' Life Sci 68(9): 1067-82. Lin, KI, Kao, YY et al. (2006). 'Reishi polysaccharides induce immunoglobulin production through the TLR4/TLR2-mediated induction of transcription factor Blimp-1.' J Biol Chem 281(34): 24111-23. Lin, ZB (2005). 'Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum.' J Pharmacol Sci 99(2): 144-53. Marchant, A, Bruyns, C et al. (1994). 'Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.' Eur J Immunol 24(5): 1167-71. Medzhitov, R and Janeway, C, Jr. (2000). 'Innate immunity.' N Engl J Med 343(5): 338-44. Medzhitov, R and Janeway, CA, Jr. (1997). 'Innate immunity: the virtues of a nonclonal system of recognition.' Cell 91(3): 295-8. Mojena, M, Hortelano, S et al. (2001). 'Protection by nitric oxide against liver inflammatory injury in animals carrying a nitric oxide synthase-2 transgene.' Faseb J 15(3): 583-5. Murphy, S, Lin, HL et al. (1995). 'Cytokine-induced expression of type II nitric oxide synthase in astrocytes is downregulated by ATP and glutamate.' Glia 15(1): 77-82. Nguyen, HB, Rivers, EP et al. (2006). 'Severe sepsis and septic shock: review of the literature and emergency department management guidelines.' Ann Emerg Med 48(1): 28-54. Nguyen, HB and Smith, D (2007). 'Sepsis in the 21st century: recent definitions and therapeutic advances.' Am J Emerg Med 25(5): 564-71. Ohlsson, K, Bjork, P et al. (1990). 'Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.' Nature 348(6301): 550-2. Onogawa, T (2005). 'Local delivery of soluble interleukin-6 receptors to improve the outcome of alpha-toxin producing Staphylococcus aureus infection in mice.' Immunobiology 209(9): 651-60. Raetz, CR, Ulevitch, RJ et al. (1991). 'Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction.' Faseb J 5(12): 2652-60. Reis e Sousa, C, Sher, A et al. (1999). 'The role of dendritic cells in the induction and regulation of immunity to microbial infection.' Curr Opin Immunol 11(4): 392-9. Rietschel, ET, Brade, H et al. (1996). 'Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification.' Curr Top Microbiol Immunol 216: 39-81. Rittirsch, D, Hoesel, LM et al. (2007). 'The disconnect between animal models of sepsis and human sepsis.' J Leukoc Biol 81(1): 137-43. Rossi, D and Zlotnik, A (2000). 'The biology of chemokines and their receptors.' Annu Rev Immunol 18: 217-42. Rudolph, K, Gourine, AV et al. (1998). 'Interleukin-6 and tumor necrosis factor-alpha during fever induced by bacterial infection.' Ann N Y Acad Sci 856: 300-3. Schroder, K, Sweet, MJ et al. (2006). 'Signal integration between IFNgamma and TLR signalling pathways in macrophages.' Immunobiology 211(6-8): 511-24. Spangelo, BL, Judd, AM et al. (1990). 'Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami.' Endocrinology 127(4): 1779-85. Vukajlovich, SW (1986). 'Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A.' Infect Immun 53(3): 480-5. Wang, YY, Khoo, KH et al. (2002). 'Studies on the immuno-modulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose-containing glycoprotein fraction responsible for the activities.' Bioorg Med Chem 10(4): 1057-62. Yoshida, A, Koide, Y et al. (1994). 'IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774.' Biochem Biophys Res Commun 198(3): 857-61. Section II. Aoyagi, Y, Isokawa, O et al. (1998). 'The fucosylation index of alpha-fetoprotein as a possible prognostic indicator for patients with hepatocellular carcinoma.' Cancer 83(10): 2076-82. Artavanis-Tsakonas, S, Rand, MD et al. (1999). 'Notch signaling: cell fate control and signal integration in development.' Science 284(5415): 770-6. Avent, ND (1997). 'Human erythrocyte antigen expression: its molecular bases.' Br J Biomed Sci 54(1): 16-37. Baboval, T, Henion, T et al. (2000). 'Molecular cloning of rat alpha1,3-fucosyltransferase IX (Fuc-TIX) and comparison of the expression of Fuc-TIV and Fuc-TIX genes during rat postnatal cerebellum development.' J Neurosci Res 62(2): 206-15. Becker, DJ and Lowe, JB (2003). 'Fucose: biosynthesis and biological function in mammals.' Glycobiology 13(7): 41R-53R. Bjoern, S, Foster, DC et al. (1991). 'Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine.' J Biol Chem 266(17): 11051-7. Cameron, HS, Szczepaniak, D et al. (1995). 'Expression of human chromosome 19p alpha(1,3)-fucosyltransferase genes in normal tissues. Alternative splicing, polyadenylation, and isoforms.' J Biol Chem 270(34): 20112-22. Chandrasekaran, EV, Xue, J et al. (2006). 'The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans.' Carbohydr Res 341(8): 983-94. Danforth, DN, Jr. and Sgagias, MK (1993). 'Tumour necrosis factor-alpha modulates oestradiol responsiveness of MCF-7 breast cancer cells in vitro.' J Endocrinol 138(3): 517-28. de Kok, JB, Roelofs, RW et al. (2005). 'Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes.' Lab Invest 85(1): 154-9. de Vries, T, Knegtel, RM et al. (2001). 'Fucosyltransferases: structure/function studies.' Glycobiology 11(10): 119R-128R. Delmotte, P, Degroote, S et al. (2002). 'Tumor necrosis factor alpha increases the expression of glycosyltransferases and sulfotransferases responsible for the biosynthesis of sialylated and/or sulfated Lewis x epitopes in the human bronchial mucosa.' J Biol Chem 277(1): 424-31. Dennis, JW, Laferte, S et al. (1987). 'Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis.' Science 236(4801): 582-5. Di Bisceglie, AM and Hoofnagle, JH (1989). 'Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B.' Cancer 64(10): 2117-20. Domino, SE and Hurd, EA (2004). 'LacZ expression in Fut2-LacZ reporter mice reveals estrogen-regulated endocervical glandular expression during estrous cycle, hormone replacement, and pregnancy.' Glycobiology 14(2): 169-75. Dontu, G, Jackson, KW et al. (2004). 'Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells.' Breast Cancer Res 6(6): R605-15. Dube, DH and Bertozzi, CR (2005). 'Glycans in cancer and inflammation--potential for therapeutics and diagnostics.' Nat Rev Drug Discov 4(6): 477-88. Duffy, MJ (2005). 'Predictive markers in breast and other cancers: a review.' Clin Chem 51(3): 494-503. Finne, J, Burger, MM et al. (1982). 'Enzymatic basis for a lectin-resistant phenotype: increase in a fucosyltransferase in mouse melanoma cells.' J Cell Biol 92(2): 277-82. Gersten, KM, Natsuka, S et al. (1995). 'Molecular cloning, expression, chromosomal assignment, and tissue-specific expression of a murine alpha-(1,3)-fucosyltransferase locus corresponding to the human ELAM-1 ligand fucosyl transferase.' J Biol Chem 270(42): 25047-56. Hakomori, S (1996). 'Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.' Cancer Res 56(23): 5309-18. Hakomori, S (2002). 'Glycosylation defining cancer malignancy: new wine in an old bottle.' Proc Natl Acad Sci U S A 99(16): 10231-3. Hanahan, D and Weinberg, RA (2000). 'The hallmarks of cancer.' Cell 100(1): 57-70. Harris, RJ, Ling, VT et al. (1992). 'O-linked fucose is present in the first epidermal growth factor domain of factor XII but not protein C.' J Biol Chem 267(8): 5102-7. Harris, RJ and Spellman, MW (1993). 'O-linked fucose and other post-translational modifications unique to EGF modules.' Glycobiology 3(3): 219-24. Idikio, HA and Manickavel, V (1991). 'Lewis blood group antigens (a and b) in human breast tissues. Loss of Lewis-b in breast cancer cells and correlation with tumor grade.' Cancer 68(6): 1303-8. Johnson, SW and Alhadeff, JA (1991). 'Mammalian alpha-L-fucosidases.' Comp Biochem Physiol B 99(3): 479-88. Kamali-Sarvestani, E, Gharesi-Fard, B et al. (2005). 'Association of TNF-alpha and TNF-beta gene polymorphism with steroid receptor expression in breast cancer patients.' Pathol Oncol Res 11(2): 99-102. Kaneko, M, Kudo, T et al. (1999). 'Alpha1,3-fucosyltransferase IX (Fuc-TIX) is very highly conserved between human and mouse; molecular cloning, characterization and tissue distribution of human Fuc-TIX.' FEBS Lett 452(3): 237-42. Kelly, RJ, Rouquier, S et al. (1995). 'Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype.' J Biol Chem 270(9): 4640-9. Kentzer, EJ, Buko, A et al. (1990). 'Carbohydrate composition and presence of a fucose-protein linkage in recombinant human pro-urokinase.' Biochem Biophys Res Commun 171(1): 401-6. Kim, YJ and Varki, A (1997). 'Perspectives on the significance of altered glycosylation of glycoproteins in cancer.' Glycoconj J 14(5): 569-76. Kimura, H, Shinya, N et al. (1997). 'Distinct substrate specificities of five human alpha-1,3-fucosyltransferases for in vivo synthesis of the sialyl Lewis x and Lewis x epitopes.' Biochem Biophys Res Commun 237(1): 131-7. Kobata, A and Amano, J (2005). 'Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours.' Immunol Cell Biol 83(4): 429-39. Koike, T, Kimura, N et al. (2004). 'Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates.' Proc Natl Acad Sci U S A 101(21): 8132-7. Kondo, A, Li, W et al. (2006). 'From glycomics to functional glycomics of sugar chains: Identification of target proteins with functional changes using gene targeting mice and knock down cells of FUT8 as examples.' Biochim Biophys Acta 1764(12): 1881-9. Kudo, T, Fujii, T et al. (2007). 'Mice lacking alpha1,3-fucosyltransferase IX demonstrate disappearance of Lewis x structure in brain and increased anxiety-like behaviors.' Glycobiology 17(1): 1-9. Kudo, T, Ikehara, Y et al. (1998). 'Expression cloning and characterization of a novel murine alpha1, 3-fucosyltransferase, mFuc-TIX, that synthesizes the Lewis x (CD15) epitope in brain and kidney.' J Biol Chem 273(41): 26729-38. Kudo, T, Kaneko, M et al. (2004). 'Normal embryonic and germ cell development in mice lacking alpha 1,3-fucosyltransferase IX (Fut9) which show disappearance of stage-specific embryonic antigen 1.' Mol Cell Biol 24(10): 4221-8. Kyprianou, P, Betteridge, A et al. (1990). 'Purification of the blood group H gene associated alpha-2-L-fucosyltransferase from human plasma.' Glycoconj J 7(6): 573-88. Larsen, RD, Ernst, LK et al. (1990). 'Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen.' Proc Natl Acad Sci U S A 87(17): 6674-8. Laubli, H, Stevenson, JL et al. (2006). 'L-selectin facilitation of metastasis involves temporal induction of Fut7-dependent ligands at sites of tumor cell arrest.' Cancer Res 66(3): 1536-42. Luo, Y and Haltiwanger, RS (2005). 'O-fucosylation of notch occurs in the endoplasmic reticulum.' J Biol Chem 280(12): 11289-94. Luo, Y, Koles, K et al. (2006). 'Protein O-fucosyltransferase 2 adds O-fucose to thrombospondin type 1 repeats.' J Biol Chem 281(14): 9393-9. Ma, B, Simala-Grant, JL et al. (2006). 'Fucosylation in prokaryotes and eukaryotes.' Glycobiology 16(12): 158R-184R. Madjd, Z, Parsons, T et al. (2005). 'High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomas.' Breast Cancer Res 7(5): R780-7. Maly, P, Thall, A et al. (1996). 'The alpha(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis.' Cell 86(4): 643-53. Mathieu, S, Prorok, M et al. (2004). 'Transgene expression of alpha(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin.' Am J Pathol 164(2): 371-83. McCurley, RS, Recinos, A, 3rd et al. (1995). 'Physical maps of human alpha (1,3)fucosyltransferase genes FUT3-FUT6 on chromosomes 19p13.3 and 11q21.' Genomics 26(1): 142-6. McGuire, WL (1980). 'Steroid hormone receptors in breast cancer treatment strategy.' Recent Prog Horm Res 36: 135-56. Menard, S, Tagliabue, E et al. (1983). 'Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.' Cancer Res 43(3): 1295-300. Michalski, JC and Klein, A (1999). 'Glycoprotein lysosomal storage disorders: alpha- and beta-mannosidosis, fucosidosis and alpha-N-acetylgalactosaminidase deficiency.' Biochim Biophys Acta 1455(2-3): 69-84. Miyoshi, E, Noda, K et al. (1999a). 'Overexpression of alpha1-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice.' Cancer Res 59(9): 2237-43. Miyoshi, E, Noda, K et al. (1999b). 'The alpha1-6-fucosyltransferase gene and its biological significance.' Biochim Biophys Acta 1473(1): 9-20. Mollicone, R, Cailleau, A et al. (1995). 'Molecular genetics of H, Se, Lewis and other fucosyltransferase genes.' Transfus Clin Biol 2(4): 235-42. Mollicone, R, Gibaud, A et al. (1990). 'Acceptor specificity and tissue distribution of three human alpha-3-fucosyltransferases.' Eur J Biochem 191(1): 169-76. Moloney, DJ and Haltiwanger, RS (1999). 'The O-linked fucose glycosylation pathway: identification and characterization of a uridine diphosphoglucose: fucose-beta1,3-glucosyltransferase activity from Chinese hamster ovary cells.' Glycobiology 9(7): 679-87. Moloney, DJ, Panin, VM et al. (2000a). 'Fringe is a glycosyltransferase that modifies Notch.' Nature 406(6794): 369-75. Moloney, DJ, Shair, LH et al. (2000b). 'Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules.' J Biol Chem 275(13): 9604-11. Muller, A, Homey, B et al. (2001). 'Involvement of chemokine receptors in breast cancer metastasis.' Nature 410(6824): 50-6. Muramatsu, T (1993). 'Carbohydrate signals in metastasis and prognosis of human carcinomas.' Glycobiology 3(4): 291-6. Natsuka, S, Gersten, KM et al. (1994). 'Molecular cloning of a cDNA encoding a novel human leukocyte alpha-1,3-fucosyltransferase capable of synthesizing the sialyl Lewis x determinant.' J Biol Chem 269(24): 16789-94. Niittymaki, J, Mattila, P et al. (2004). 'Cloning and expression of murine enzymes involved in the salvage pathway of GDP-L-fucose.' Eur J Biochem 271(1): 78-86. Nilsson, T, Rabouille, C et al. (1996). 'The role of the membrane-spanning domain and stalk region of N-acetylglucosaminyltransferase I in retention, kin recognition and structural maintenance of the Golgi apparatus in HeLa cells.' J Cell Sci 109 ( Pt 7): 1975-89. Nilsson, T, Slusarewicz, P et al. (1993). 'Kin recognition. A model for the retention of Golgi enzymes.' FEBS Lett 330(1): 1-4. Nishihara, S, Iwasaki, H et al. (1999). 'Alpha1,3-fucosyltransferase 9 (FUT9; Fuc-TIX) preferentially fucosylates the distal GlcNAc residue of polylactosamine chain while the other four alpha1,3FUT members preferentially fucosylate the inner GlcNAc residue.' FEBS Lett 462(3): 289-94. Nishimura, H, Takao, T et al. (1992). 'Human factor IX has a tetrasaccharide O-glycosidically linked to serine 61 through the fucose residue.' J Biol Chem 267(25): 17520-5. Noda, K, Miyoshi, E et al. (1998). 'Gene expression of alpha1-6 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of alpha-fetoprotein.' Hepatology 28(4): 944-52. Ohtsubo, K and Marth, JD (2006). 'Glycosylation in cellular mechanisms of health and disease.' Cell 126(5): 855-67. Okajima, T and Irvine, KD (2002). 'Regulation of notch signaling by o-linked fucose.' Cell 111(6): 893-904. Okajima, T, Xu, A et al. (2005). 'Chaperone activity of protein O-fucosyltransferase 1 promotes notch receptor folding.' Science 307(5715): 1599-603. Olayioye, MA, Neve, RM et al. (2000). 'The ErbB signaling network: receptor heterodimerization in development and cancer.' Embo J 19(13): 3159-67. Olefsky, JM (2001). 'Nuclear receptor minireview series.' J Biol Chem 276(40): 36863-4. Oriol, R, Mollicone, R et al. (1999). 'Divergent evolution of fucosyltransferase genes from vertebrates, invertebrates, and bacteria.' Glycobiology 9(4): 323-34. Panin, VM, Shao, L et al. (2002). 'Notch ligands are substrates for protein O-fucosyltransferase-1 and Fringe.' J Biol Chem 277(33): 29945-52. Patnaik, SK, Zhang, A et al. (2000). 'alpha(1,3)fucosyltransferases expressed by the gain-of-function Chinese hamster ovary glycosylation mutants LEC12, LEC29, and LEC30.' Arch Biochem Biophys 375(2): 322-32. Pece, S, Serresi, M et al. (2004). 'Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis.' J Cell Biol 167(2): 215-21. Pendl, GG, Robert, C et al. (2002). 'Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1.' Blood 99(3): 946-56. Roodi, N, Bailey, LR et al. (1995). 'Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.' J Natl Cancer Inst 87(6): 446-51. Roos, C, Kolmer, M et al. (2002). 'Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolism.' J Biol Chem 277(5): 3168-75. Ruoslahti, E, Salaspuro, M et al. (1974). 'Serum alpha-fetoprotein: diagnostic significance in liver disease.' Br Med J 2(5918): 527-9. Sarnesto, A, Kohlin, T et al. (1990). 'Purification of H gene-encoded beta-galactoside alpha 1----2 fucosyltransferase from human serum.' J Biol Chem 265(25): 15067-75. Sato, Y, Nakata, K et al. (1993). 'Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein.' N Engl J Med 328(25): 1802-6. Sawa, M, Hsu, TL et al. (2006). 'Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo.' Proc Natl Acad Sci U S A 103(33): 12371-6. Schiffer, SG, Foley, S et al. (2001). 'Fucosylation of Cripto is required for its ability to facilitate nodal signaling.' J Biol Chem 276(41): 37769-78. Schioppa, T, Uranchimeg, B et al. (2003). 'Regulation of the chemokine receptor CXCR4 by hypoxia.' J Exp Med 198(9): 1391-402. Schottelius, AJ, Hamann, A et al. (2003). 'Role of fucosyltransferases in leukocyte trafficking: major impact for cutaneous immunity.' Trends Immunol 24(3): 101-4. Shi, S and Stanley, P (2003). 'Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways.' Proc Natl Acad Sci U S A 100(9): 5234-9. Shiraki, K, Takase, K et al. (1995). 'A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients.' Hepatology 22(3): 802-7. Smithson, G, Rogers, CE et al. (2001). 'Fuc-TVII is required for T helper 1 and T cytotoxic 1 lymphocyte selectin ligand expression and recruitment in inflammation, and together with Fuc-TIV regulates naive T cell trafficking to lymph nodes.' J Exp Med 194(5): 601-14. Soriano, JV, Uyttendaele, H et al. (2000). 'Expression of an activated Notch4(int-3) oncoprotein disrupts morphogenesis and induces an invasive phenotype in mammary epithelial cells in vitro.' Int J Cancer 86(5): 652-9. Staudacher, E, Altmann, F et al. (1999). 'Fucose in N-glycans: from plant to man.' Biochim Biophys Acta 1473(1): 216-36. Steplewska-Mazur, K, Gabriel, A et al. (2000). 'Breast cancer progression and expression of blood group-related tumor-associated antigens.' Hybridoma 19(2): 129-33. Stylianou, S, Clarke, RB et al. (2006). 'Aberrant activation of notch signaling in human breast cancer.' Cancer Res 66(3): 1517-25. Taketa, K, Endo, Y et al. (1993). 'A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma.' Cancer Res 53(22): 5419-23. Taketa, K, Sekiya, C et al. (1990). 'Lectin-reactive profiles of alpha-fetoprotein characterizing hepatocellular carcinoma and related conditions.' Gastroenterology 99(2): 508-18. Tonetti, M, Sturla, L et al. (1996). 'Synthesis of GDP-L-fucose by the human FX protein.' J Biol Chem 271(44): 27274-9. Wang, X, Inoue, S et al. (2005). 'Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice.' Proc Natl Acad Sci U S A 102(44): 15791-6. Wang, Y, Shao, L et al. (2001). 'Modification of epidermal growth factor-like repeats with O-fucose. Molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase.' J Biol Chem 276(43): 40338-45. Wang, Y and Spellman, MW (1998). 'Purification and characterization of a GDP-fucose:polypeptide fucosyltransferase from Chinese hamster ovary cells.' J Biol Chem 273(14): 8112-8. Wiese, TJ, Dunlap, JA et al. (1994). 'L-fucose is accumulated via a specific transport system in eukaryotic cells.' J Biol Chem 269(36): 22705-11. Witz, IP (2006). 'The involvement of selectins and their ligands in tumor-progression.' Immunol Lett 104(1-2): 89-93. Yamashita, F, Tanaka, M et al. (1996). 'Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas.' Gastroenterology 111(4): 996-1001. Yamashita, K, Ohkura, T et al. (1984). 'Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis.' J Biol Chem 259(17): 10834-40. Yan, YT, Liu, JJ et al. (2002). 'Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway.' Mol Cell Biol 22(13): 4439-49. Zhang, S, Cordon-Cardo, C et al. (1997a). 'Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides.' Int J Cancer 73(1): 42-9. Zhang, S, Zhang, HS et al. (1997b). 'Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens.' Int J Cancer 73(1): 50-6. Zlotnik, A (2006). 'Chemokines and cancer.' Int J Cancer 119(9): 2026-9. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/25109 | - |
dc.description.abstract | Section I. Potentials of Chinese herbal medicine in ameliorating septic shock
Previous studies have shown that the fucose-containing glycoprotein fraction 3 (Reishi-F3) purified from the ancient Chinese herb – Ganoderma lucidum (Reishi) extract contains active components that could activate immune cells and exhibit anti-tumor properties. Although these studies pointed out the feasibility of Reishi-F3 as a potential botanical drug, like any other investigational agent, Reishi-F3 must show evidence of relative purity, safety, and effectiveness before it can be used in the clinical trials. Despite of the fact that it was shown earlier that Reishi-F3 was adjudged pyrogenic by both the rabbit pyrogen test and the Limulus amebocyte lysate test, we argued that the pyrogenicity of Reishi-F3 may not be entirely attributed to the contamination by endotoxins. With this goal in mind, we sought to distinguish the biological properties of lipopolysaccharide (LPS) and Reishi-F3 by the LPS-induced mortality test in mice. While a majority of the mice which received a lethal dose of LPS died within 48 hours after injection, mice injected with an equivalent dose of Reishi-F3 showed 100% survivability. We also followed up by assaying the levels of different cytokines in the serum samples of each mouse. Interestingly, we noted the inductions of many of the pro-inflammatory cytokines such as interleukin-1 (IL-1), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) were missing in mice treated with Reishi-F3. Furthermore, Reishi-F3 induced a higher serum level of IL-10 in comparison to LPS. Based on our results above, we were interested in investigating whether Reishi-F3 possesses anti-inflammatory properties. Unfortunately, we determined that the pre-treatment of Reishi-F3 does not protect the mice from later challenge with LPS. Hirsutella hepiali (Hirsutella) is the proprietary strain of the popular Chinese herbal medicine Cordyceps sinensis. It has been reported that Cordyceps sinensis could protect against viral infection and suppress inflammation. We discovered that pre-treatment of mice with the crude extract of Hirsutella could indeed protect the mice from LPS-induced endotoxic lethality. By monitoring the levels of different cytokines in the mouse serum after treatment of Hirsutella and subsequent injection of LPS, we showed that treatment of Hirsutella alone at relatively low dose was capable of lowering the levels of several cytokines in the mouse serum. More importantly, treatment with Hirsutella appears to prime the animal for later exposure to LPS, resulting in increased secretion of the cytokine IL-1 receptor antagonist (IL-1Ra) upon LPS challenge. On the other hand, measurement of IL-1Ra suggested that Hirsutella alone would not lead to an increase in the secretion of IL-1Ra into the mouse serum. Since IL-1Ra is known as an inhibitor of IL-1 and attenuate injury caused by inflammation, we surmised that Hirsutella ameliorates LPS-induced endotoxic shock via an increased production of IL-1Ra, though the exact mechanism has yet to be determined. Section II: Fucosyltransferases in breast cancer Fucose is a deoxyhexose that is commonly found as a terminal modification of many N- and O-linked glycans. The transfer of fucose residues onto existing glycan structures is carried out by enzymes known as fucosyltransferases and 13 fucosyltransferases have been identified in the human genome thus far. Fucosylated glycans have been implicated in the pathogenesis of several human diseases including cancer, in which altered expressions of particular type of fucosylated epitopes were often seen on the surface of tumor cells. However, it remains to be resolved whether carcinogenesis could be directly linked to the changes in the expressions of the fucosyltransferase. We therefore determined the expression levels of all 13 fucosyltransferase genes in 63 pairs of primary breast tumor and normal specimens. Pre-processing of the data by Genespring clustering analysis showed that the normal and tumor samples roughly formed their own distinct clusters and were easily distinguishable. Statistical analyses also indicated correlation between the expression profiles of FUT genes with tumor grade, size, stage, and status of predictive markers such as the estrogen and progesterone receptors and HER-2. Interestingly, we found that the expressions of FUT1, FUT4-5, FUT8, and FUT10-13 were significantly downregulated in breast tumors as opposed to normal tissues, whereas increased expressions of FUT2 and FUT7 were seen in most tumor samples. Here, we also relate our findings to the current knowledge of fucosyltransferases and fucosylation patterns from scientific publications, though more thorough studies are needed to further examine the actual functions and products of each fucosyltransferase in order to clarify the roles these enzymes play in the development of breast cancer. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T06:02:32Z (GMT). No. of bitstreams: 1 ntu-96-R94b46043-1.pdf: 1336076 bytes, checksum: 713d46d0fd7283c6e93d192bbb319f0f (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | Section I. Potentials of Chinese herbal medicine in ameliorating septic shock
1. Abstract 1 1. Abstract in Chinese 3 1.1 Introduction 4 1.2 Materials and methods 11 1.3 Results 17 1.4 Discussions 22 1.5 Conclusion 29 Figures 30 1.6 References 52 Section II. Fucosyltransferases in breast cancer 2. Abstract 57 2. Abstract in Chinese 58 2.1 Introduction 59 2.2 Materials and methods 65 2.3 Results 69 2.4 Discussions 72 2.5 Conclusion 83 Figures 84 Tables 87 2.6 References 95 Appendix 103 | |
dc.language.iso | en | |
dc.title | 1.中草藥於改善敗血性休克之研究
2.岩藻醣轉移酶在乳癌之探討 | zh_TW |
dc.title | 1.Potentials of Chinese herbal medicine in ameliorating septic shock
2.Fucosyltransferases in breast cancer | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 陳鈴津(Alice L. Yu) | |
dc.contributor.oralexamcommittee | 林國儀(Kuo-I Lin),蕭宏昇(Michael Hsiao) | |
dc.subject.keyword | 靈芝, 敗血性休克, 岩藻醣轉移酶,, 乳癌, | zh_TW |
dc.subject.keyword | Reishi, septic shock, fucosyltranferase, breast cancer, | en |
dc.relation.page | 102 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2007-07-27 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生化科學研究所 | zh_TW |
顯示於系所單位: | 生化科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 1.3 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。